Assessment of In-Vitro Synergy of Fosfomycin with Meropenem, Amikacin and Tigecycline in Whole Genome Sequenced Extended and Pan Drug Resistant <i>Klebsiella Pneumoniae</i>: Exploring A Colistin Sparing Protocol

Assessment of In-Vitro Synergy of Fosfomycin with Meropenem, Amikacin and Tigecycline in Whole Genome Sequenced Extended and Pan Drug Resistant <i>Klebsiella Pneumoniae</i>: Exploring A Colistin Sparing Protocol

Fosfomycin has emerged as a very useful antimicrobial in management of extremely drug resistant (XDR) and pan drug resistant (PDR) <i>Klebsiella pneumoniae</i>. In this study, we assessed in-vitro synergy of colistin sparing combinations of fosfomycin (FOS) with meropenem (MEM), tigecycl...

Full description

Bibliographic Details
Main Authors: Manawr AL-Quraini, Meher Rizvi, Zaaima AL-Jabri, Hiba Sami, Muna AL-Muzahmi, Zakariya AL-Muharrmi, Neelam Taneja, Ibrahim AL-Busaidi, Rajeev Soman
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Antibiotics
Subjects:
in-vitro synergy
checkerboard assay
time kill assay
fosfomycin
meropenem
<i>Klebsiella pneumoniae</i>
Online Access:https://www.mdpi.com/2079-6382/11/2/153

Internet

https://www.mdpi.com/2079-6382/11/2/153

Similar Items